Abstract
Curcumin, a polyphenolic compound derived from the turmeric plant (Curcuma longa), has been extensively studied for its anti-inflammatory and anti-proliferative properties. The safety and efficacy of curcumin have been thoroughly validated. Nevertheless, the underlying mechanism for treating osteoarthritis remains ambiguous. This study aims to reveal the potential mechanism of curcumin in treating osteoarthritis by using metabolomics and transcriptomics. Firstly, we validated the effect of curcumin on inflammatory factors in human articular chondrocytes. Secondly, we explored the cellular metabolism mechanism of curcumin against osteoarthritis using cell metabolomics. Thirdly, we assessed the differences in gene expression of human articular chondrocytes through transcriptomics. Lastly, to evaluate the essential targets and elucidate the potential mechanism underlying the therapeutic effects of curcumin in osteoarthritis, we conducted a screening of the proteins within the shared pathway of metabolomics and transcriptomics. Our results demonstrated that curcumin significantly decreased the levels of inflammatory markers, such as IL-β, IL-6, and TNF-α, in human articular chondrocytes. Cell metabolomics identified 106 differential metabolites, including beta-aminopropionitrile, 3-amino-2-piperidone, pyrrole-2-carboxaldehyde, and various other components. The transcriptomic analysis yielded 1050 differential mRNAs. Enrichment analysis showed that the differential metabolites and mRNAs were significantly enriched in seven pathways, including glycine, serine, and threonine metabolism; pentose and glucuronate interconversions; glycerolipid metabolism; histidine metabolism; mucin-type o-glycan biosynthesis; inositol phosphate metabolism; and cysteine and methionine metabolism. A total of 23 key targets were identified to be involved in these pathways. We speculate that curcumin may alleviate osteoarthritis by targeting key proteins involved in glycine, serine, and threonine metabolism; inhibiting pyruvate production; and modulating glycolysis.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Osteoarthritis is widely recognized as a prevalent degenerative joint disease that significantly impacts the elderly population and is a primary contributor to disability worldwide. It affects approximately 200 million individuals globally (Liu et al., 2020). The prevalence of osteoarthritis among individuals aged 65 years and above can reach as high as 50%. Osteoarthritis has become a growing concern to doctors, patients, and society due to the aging population and increasing life expectancy. Joint pain is the most prominent symptom in patients with osteoarthritis and is often the main reason for seeking medical assistance (Carcolé et al., 2019). Furthermore, long-term chronic pain also negatively affects the psychological, spiritual, sleep, and social activities of patients (Miller et al., 2020; You et al., 2022), severely impacting the overall well-being of patients and imposing significant burdens on both individuals and society as a whole (Tajerian et al., 2018). Clinical and epidemiological studies have identified several factors associated with the development of osteoarthritis, including aging, obesity, joint instability, trauma, and joint inflammation (Chang et al., 2019). Furthermore, osteoarthritis is also affected by factors such as sex, genetics, and joint anatomy (Shen et al., 2019).
There are various pathological changes in the ligaments, muscles, cartilage, osteophytes, and synovial tissue of the affected joints, which may ultimately lead to the manifestation of symptoms such as joint deformity and dysfunction, and in severe cases, complete loss of joint function. Among these pathological changes, the deterioration of cartilage plays a significant role in the progression of osteoarthritis (Schulze-Tanzil, 2019). Cartilage is a white avascular and innervated tissue that covers the surface of joints (Bergholt et al., 2016). Cartilage plays a crucial role in dispersing joint bearing forces, cushioning impacts, and minimizing friction within and between joints (Rowland et al., 2018). Extracellular matrix (ECM) and chondrocytes are the main components of cartilage. ECM accounts for more than 90% of cartilage components. The primary constituents of ECM are proteoglycans and collagen fibers, which are essential for stress distribution in articular cartilage. Chondrocytes represent the sole cell type currently identified within cartilage. The deterioration of cartilage is firstly the change of the microenvironment of cartilage, and chondrocytes play an important role in maintaining the synthesis and metabolic balance of extracellular protein matrix within cartilage (Jeon et al., 2017). Currently, there are several treatment options for osteoarthritis, with pain relief and cartilage repair medication being the most frequently used approaches. The most commonly prescribed medications for pain associated with osteoarthritis are nonsteroidal anti-inflammatory drugs and opioid pain relievers. Several studies have highlighted safety concerns related to the long-term use of oral nonsteroidal anti-inflammatory drugs, such as hepatotoxicity, nephrotoxicity, increased risk of hypertension, and other cardiovascular events, as well as multiple adverse effects on the upper gastrointestinal tract (Iolascon et al., 2021; Lam et al., 2019; Wanchoo et al., 2017; Yoon et al., 2023; Frantz et al., 2018). Therefore, it is crucial to identify a pharmaceutical agent that offers improved safety and effectiveness in the treatment of osteoarthritis.
Turmeric (Curcuma longa L.), a traditional Chinese medicine, possesses anti-inflammatory properties attributed to its polyphenol curcuminoids (Panknin et al., 2023). Curcumin, a polyphenolic compound derived from the plant Curcuma longa, has been used for the treatment of many diseases, including cardiovascular disease, diabetes, and autoimmune diseases (Zhang & Zeng, 2019; Yaribeygi et al., 2023; Ataei et al., 2023; Kou et al., 2023). It has anti-inflammatory and anti-proliferative properties (Razali et al., 2022; Luo et al., 2023). Furthermore, it exhibits immunomodulatory effects on pathways responsible for regulating immune responses (Atabaki et al., 2020). The anti-osteoarthritis effect of curcumin has been reported in recent years. For example, both curcumin and tetrahydrocurcumin can prevent osteoarthritis symptoms and reduce the expression of pro-inflammatory cytokines in rats with estrogen deficiency (Zhang et al., 2023; Park et al., 2016). However, the underlying mechanism remains largely unclear.
Herein, we investigated the potential mechanism of curcumin in treating osteoarthritis by using metabolomics and transcriptomics. The potential targets and signaling pathways of curcumin in the treatment of osteoarthritis were identified and analyzed. This study offers novel insights and innovative approaches for conducting thorough investigations on the treatment of osteoarthritis.
Materials and methods
Culture and subculture of human articular chondrocytes
Human articular chondrocytes were obtained from Procell Life Science & Technology Co., Ltd. (Wuhan, China). The cells were cultured in the complete human articular chondrocyte complete culture medium (Procell) supplemented with 0.25% trypsin solution (Batch number: WH1622G051) and PBS buffer solution (Batch number: WH0022A071), both from Wuhan Puno Bio-Life Technology Co., Ltd. The culture was conducted in a 5% CO2, 20% O2, 37 °C incubator for 2 days. Subsequently, the medium was replaced, and the cells were subcultured at a cell confluence of 70–80%. When the confluence of the second passage chondrocytes reached 70–80%, the chondrocytes were digested with 0.25% trypsin (Procell Life Science &Technology Co., Ltd.), rinsed once with PBS, and centrifuged at 1500 ×g for 5 min. After re-suspension, the chondrocytes were seeded into 25 cm2 cell culture flasks, placed in the incubator for routine culture and passage, and regularly observed under an inverted microscope.
Cell treatment and grouping
The chondrocytes of the second passage were divided into the blank group, the model group, the curcumin group, and the meloxicam group. The model group was intervened with 10 ng/mL of IL-1β (Multisciences (Lianke) Biotech, Co., Ltd., Hangzhou, China). The curcumin group was treated with 10 ng/mL of IL-1β and 10 μM of curcumin (MedChemexpress Biotechnology Inc., Princeton, NJ, USA). Cells in the meloxicam group received treatment with 10 ng/mL of IL-1β and 10 μM of meloxicam (MedChemexpress Biotechnology Inc.). Each group was intervened for 24 h, and 10 replicate wells were set up for each group. The cells in the blank group were cultured without any interventions.
CCK-8 assay
Cell viability was detected with the CCK-8 kit (Elabscience Biotechnology Co., Ltd., Wuhan, China). Briefly, cells were seeded into a 96-well plate (5 × 103/well). After culture for 24 h, cells were treated with curcumin (5 μM, 25 μM, 50 μM, 100 μM, and 200 μM) or meloxicam (5 μM, 10 μM, 20 μM, 100 μM, and 200 μM) for 24 h and 48 h. A blank control group was set up. Each group had 6 replicate wells. Following the intervention, 10 μL of CCK-8 solution was added to each well and incubated for 2 h. The optical density at 450 nm wavelength was then detected with a microplate reader.
ELISA
The inflammatory factors IL-1β, IL-6, and TNF-α were measured using the Human IL-1β/IL-6/TNF-α ELISA kits (Shanghai Enzyme-linked Biotechnology Co., Ltd., China) following the kit instructions (Yoshizumi et al., 2016). The optical density at 450 nm wavelength was detected with a microplate reader.
Metabolomics analysis
Metabolites extraction
The chondrocytes were mixed with 200 μL of water, followed by vortexing for 30 s. The samples were then subjected to three freeze-and-thaw cycles using liquid nitrogen. Next, the samples were sonicated for 10 min in an ice water bath. Protein was quantified using 50 μL of the homogenate. Subsequently, 600 μL of pre-cooled extract (− 40 °C) consisting of methanol and acetonitrile in a 1:1 ratio was added to the homogenized solution. After vortexing for 30 s, the samples were sonicated in an ice-water bath for 10 min, incubated at – 40 °C for 1 h, and then centrifuged at 24000 ×g at 4 °C for 15 min. A total of 700 μL of supernatant was transferred to EP tubes and dried in a vacuum concentrator. Subsequently, a solution consisting of methanol, acetonitrile, and water in a 2:2:1 ratio, supplemented with an isotopically labeled internal standard mixture, was introduced (Alseekh & Aharoni, 2021; Doppler et al., 2016). After vortexing for 30 s, the samples were sonicated for 10 min in an ice-water bath and centrifuged at 24000 ×g for 15 min at 4 °C. The resulting supernatant was transferred into a new glass bottle for LC/MS analysis. Quality control samples were prepared by combining aliquots of all sample supernatants.
LC-MS/MS analysis
LC-MS/MS analysis was performed using a UHPLC system (Vanquish, Thermo Fisher Scientific) equipped with a UPLC BEH Amide column (2.1 mm × 100 mm, 1.7 μm) and coupled with a Q Exactive HFX mass spectrometer (Orbitrap MS, Thermo) (Dunn et al., 2011; Want et al., 2010; Peng et al., 2015). The mobile phase consisted of 25 mmol/L ammonium acetate, 25 mmol/L aqueous ammonium hydroxide (pH = 9.75), and acetonitrile. The autosampler temperature was 4 °C, and the injection volume was 4 μL. The full scan MS/MS spectra were obtained in the Information Dependent Acquisition mode of the Q Exactive HFX mass spectrometer using the acquisition software (Xcalibur, Thermo). The ESI source conditions were sheath gas flow rate of 30 Arb, auxiliary gas flow rate of 25 Arb, capillary temperature of 350 °C, full MS resolution of 120,000, MS/MS resolution of 7500, collision energy of 10/30/60 NCE mode, spray voltage of 3.6 kV (positive) or − 3.2 kV (negative), respectively.
Data preprocessing and annotation
The raw data was converted to the mzXML format using ProteoWizard. Subsequently, an in-house program developed in R and based on XCMS (Smith et al., 2006) was used for peak detection, extraction, alignment, and integration. An in-house MS2 database (BiotreeDB) was then applied for metabolite annotations. The cutoff value for annotations was set at 0.3.
RNA extraction, library construction, and sequencing
RNA was extracted and quantified by Shanghai Biotree Biomedical Technology Co., Ltd. An mRNA library was constructed, and sequence filtering and alignment were performed. The gene expression level was characterized using Stringtie and TMM, and FPKM values were calculated. The differential expression fold change (FC) was also calculated (Pertea et al., 2016; Kovaka et al., 2019; Pertea et al., 2015; Wang et al., 2020). Gene expression Q value was calculated using edgeR3 software. Differential genes were identified based on a Q value < 0.05 and FC > 2 or FC < 0.5 (Sahraeian et al., 2017; Robinson et al., 2010). Cluster analysis was performed using the Bioconductor package in R. Venn diagrams were generated by identifying common genes using Venn 2.1.0 (http://bioinformatics.psb.ugent.be/webtools/Venn/).
Data analysis for metabolomics and transcriptomics
To reduce data dimensionality and visualize relationships of the metabolomics data, we utilized principal component analysis (PCA), a widely used technique for decreasing dataset dimensionality and revealing underlying structures (Abdi & Williams, 2010). For identifying differential metabolites, we conducted orthogonal partial least squares discriminant analysis (OPLS-DA), which incorporates orthogonal projections to latent structures and is suitable for handling multivariate and highly correlated data (Boccard & Rutledge, 2013). Metabolites with a VIP (Variable Importance in Projection) value greater than 1 and a p-value less than 0.05 (determined by the Student t-test) were considered to be significantly altered. Additionally, we utilized MetaboAnalyst 5.0, a powerful online metabolomics data analysis tool that offers a variety of analysis tools and statistical methods for preprocessing, exploratory data analysis, biological interpretation, and data visualization of high-throughput metabolomics data (Pang et al., 2021), to perform a joint analysis of metabolomics and transcriptomics.
Statistical analysis
The statistical analysis for this study was conducted using SPSSAU (Statistical Product and Service Software Automatically) (Version 23.0), a web-based data analysis platform (spssau.com). The correlation between the two parameters was determined using the Spearman correlation. Wilcoxon tests were used to compare differences between two groups, while Kruskal-Wallis tests were employed for comparisons involving three or more groups. Statistically significant results were defined as bilateral p-values less than 0.05.
Results
Determination of the optimal concentrations of curcumin and meloxicam
Human articular chondrocytes were treated with different concentrations of curcumin (0 μM, 5 μM, 10 μM,15 μM, 20 μM, and 50 μM) and meloxicam (0 μM, 1 μM, 5 μM, 10 μM, 15 μM, and 20 μM) for 24 h and 48 h, respectively. Then, cell viability was detected with CCK-8 assay. The results showed that the cell viability of human articular chondrocytes was the highest when 10 μM of curcumin and meloxicam was used (Fig. 1A and B). Thus, both curcumin and meloxicam exhibited protective effects in human articular chondrocytes, with the concentration of 10 μM proving to be the most effective.
Curcumin decreases the secretion of inflammatory cytokines in human articular chondrocytes
In this study, to determine whether curcumin exerts anti-inflammatory effects, we measured the levels of IL-β, IL-6, and TNF-α in the culture supernatants of human articular chondrocytes by using ELISA. Compared with the model group, the concentrations of IL-1β (Fig. 2A), IL-6 (Fig. 2B), and TNF-α (Fig. 2C) in the blank group, curcumin group, and meloxicam group were significantly decreased (p < 0.05). In addition, the concentrations of IL-1β, IL-6, and TNF-α were significantly reduced in the curcumin group compared with the meloxicam group (p < 0.05). The results demonstrate that curcumin could reduce the secretion of inflammatory cytokines in human articular chondrocytes, exerting an anti-inflammatory effect.
Changes in human chondrocyte metabolite profile in each group
The profiles of human chondrocyte metabolites in each group were analyzed using PCA. As illustrated in Fig. 3A, the blank group, model group, curcumin group, and meloxicam group were located in distinct dimensions, suggesting that there are variations in the metabolite profiles of human articular chondrocytes among the four groups. Fig. 3B and C further demonstrate that the model group was differentiated from the blank group and the curcumin group, indicating significant differences in the metabolites of human chondrocytes across the various groups.
Screening of differential metabolites in human chondrocytes of each group
To further identify the differential metabolites among the model group, the blank group, and the curcumin group, we performed OPLS-DA and conducted a permutation test. Metabolites with a VIP (Variable Importance in Projection) value greater than 1 and a p-value less than 0.05 (determined by the Student t-test) were regarded as significantly changed metabolites. As shown in Fig. 4, the model R2Y was very close to 1, and Q2 was relatively close to 1, indicating that the established model is in line with the real situation of the sample data, and the difference between the two groups of samples is significant. The hierarchical cluster analysis was conducted on differential metabolites, and a heat map was plotted. There were 314 differential metabolites between the blank group and the model group (Fig. 5A) and 279 differential metabolites between the model group and the curcumin group (Fig. 5B).
Statistical analysis of differential metabolites
After identifying the common metabolites between the model group and the blank group, as well as between the model group and the curcumin group, statistical analysis was conducted using SPSSAU (Version 23.0) to determine the normalized peak areas of the metabolites. Finally, 106 significantly different metabolites were identified (Table 1).
Analysis of differential mRNA in human articular chondrocytes
Compared with the blank group, the model group had a total of 4780 differentially expressed genes (DEGs), of which 2685 were upregulated and 2095 were downregulated. Compared with the model group, there were 7595 DEGs in the curcumin group, of which 3343 were upregulated and 4252 were downregulated. The cluster analysis of the differentially expressed genes (DEGs) in the three groups revealed a total of 1050 DEGs that were dysregulated in the model group and restored by curcumin, as illustrated in Fig. 6.
Integrative analysis of metabolomics and transcriptomics
The biological pathway analysis of metabolite-gene interactions was performed on 106 differential metabolites and 1050 DEGs using the joint pathway analysis module on MetaboAnalyst 5.0 (https://genap.metaboanalyst.ca/MetaboAnalyst/upload/JointUploadView.xhtml). Enrichment analysis showed that the identified proteins and metabolites were significantly enriched in specific pathways (Fig. 7) (p < 0.05), including glycine, serine and threonine metabolism, pentose and glucuronate interconversions, glycerolipid metabolism, histidine metabolism, mucin-type o-glycan biosynthesis, inositol phosphate metabolism, and cysteine and methionine metabolism. These seven metabolic pathways may be the key pathways for curcumin to treat osteoarthritis.
By screening the targets in these seven key pathways, we obtained 23 core targets after deduplication. Detailed information about these targets can be found in Table 2. A network of “curcumin-key target-key pathway-osteoarthritis” was constructed to reveal the mechanism of curcumin in treating osteoarthritis (Fig. 8). In this network, it can be seen that curcumin may exert treatment effects on osteoarthritis via multiple targets and multiple pathways. For instance, curcumin may exhibit therapeutic effects on osteoarthritis by modulating the CBS, CTH, PSAT1, MAOA, and AOC2 proteins involved in the metabolism of glycine, serine, and threonine. Additionally, curcumin can exert therapeutic effects on osteoarthritis by targeting the PIP4K2C, INPP5J, ITPKA, ITPKB, ISYNA1, and PLCH2 proteins associated with inositol phosphate metabolism. Moreover, curcumin may have therapeutic effects on osteoarthritis by interacting with the CTH, CBS, CDO1, and PSAT1 proteins involved in cysteine and methionine metabolism.
Discussion
The treatment of diseases in traditional Chinese medicine is characterized by its multi-component, multi-target, and multi-pathway approach. Metabolomics allows for the detection of changes in endogenous metabolites, while transcriptomics can reveal patterns of gene expression during physiological development and the occurrence of diseases. The combination of transcriptomics and metabolomics provides a promising strategy to unravel the mechanism by which traditional Chinese medicine treats diseases. In our study, we validated the anti-inflammatory properties of curcumin on osteoarthritis in human articular chondrocytes and identified 106 differential metabolites. Clustering analysis of transcriptomics was conducted on the DEGs in the blank group, model group, and curcumin group. A total of 1050 mRNAs were found to be dysregulated in the model group and subsequently rescued by curcumin treatment. By integrating the potential pathways derived from metabolomics and transcriptomics, we identified seven shared pathways as key pathways, namely, glycine, serine, and threonine metabolism; histidine metabolism; pentose and glucuronate interconversions; glycerolipid metabolism; mucin-type O-glycan biosynthesis; inositol phosphate metabolism; cysteine and methionine metabolism; and beta-alanine metabolism. By screening the proteins within these key pathways, we identified a total of 23 key targets.
Current studies have shown that curcumin, a natural compound, possesses promising anti-osteoarthritis properties (Kotha & Luthria, 2019; Zeng et al., 2022; Nakagawa et al., 2020; Thomas et al., 2021). In a mouse model of posttraumatic osteoarthritis (Zhang et al., 2016), curcumin has been found to slow the progression of osteoarthritis and relieve its symptoms by reducing the levels of MMP-1, MMP-3, MMP-13, ADAMTS5, IL-1β, and TNF-α. Consistently, we found that curcumin significantly decreased the levels of inflammatory markers IL-β, IL-6, and TNF-α in human articular chondrocytes, exerting anti-inflammation effects. Acid-activatable curcumin polymer micelles significantly protect joint structures from arthritis by inhibiting TNF-α and IL-1β (Kang et al., 2020). Curcuma longa L. was found to be more effective than a placebo in alleviating knee pain without affecting knee effusion-synovitis or cartilage composition (Srivastava et al., 2016). Research has shown that the intake of curcumin twice daily for a duration of 4 weeks improves PGE2 levels in patients with chronic knee osteoarthritis, similar to naproxen (Heidari-Beni & Moravejolahkami, 2020). Various functions of curcumin act synergistically to exert a therapeutic effect on osteoarthritis. Our study demonstrates that curcumin may alleviate osteoarthritis by acting on key proteins in glycine, serine, and threonine metabolism, inhibiting pyruvate production and regulating glycolysis.
After curcumin intervention, there were changes observed in glycine, serine, and threonine metabolism. Specifically, the expression of 2-phospho-d-glyceric acid increased, while the expression of pyruvic acid (pyruvate) and l-methionine decreased. Moreover, the relative mRNA expression levels of cystathionine-β-synthase (CBS), PSAT1, and MAOA were upregulated, while the relative mRNA expression levels of AOC2 and CTH were downregulated. In pentose and glucuronate interconversions, there was an increase in the expression of 2-phospho-d-glyceric acid, but a decrease in the expression of d-glucuronic acid, d-xylitol, and imidazole-4-acetaldehyde. Additionally, the relative expression of DCXR and DHDH mRNA was downregulated. In glycerolipid metabolism, the expression of 2-phospho-d-glyceric acid increased, and the expression of pyruvic acid decreased following curcumin intervention. The relative mRNA expression of DGAT2 and PLPP2 increased, whereas the relative mRNA expression of GPAT3 and PLPP4 decreased. In histidine metabolism, there was an increase in the expression of d-2,3-dihydroxypropanoic acid and a decrease in the expression of d-xylose and urocanic acid. Furthermore, the relative expression of MAOA and ALDH3B1 mRNA increased. In mucin-type O-glycan biosynthesis, the relative mRNA expression of GALNT5 and GALNT15 increased, while the relative mRNA expression of GALNT3 and POC1B-GALNT4 was downregulated. In inositol phosphate metabolism, the expression of imidazole-4-acetaldehyde decreased. Additionally, the relative mRNA expression of PLCH2 increased, while the relative mRNA expression of PIP4K2C, INPP5J, ITPKA, ITPKB, and ISYNA1 was downregulated. Lastly, in cysteine and methionine metabolism, the expression of methylimidazole acetaldehyde and l-methionine decreased. Conversely, the relative mRNA expression of PSAT1 and CBS increased, while the relative mRNA expression of CTH and CDO1 decreased.
Previous research has demonstrated that curcumin, an anti-inflammatory compound, has a potential therapeutic effect in osteoarthritis (Koroljević et al., 2023). Our research results suggest that curcumin may play a role in the treatment of osteoarthritis by regulating the metabolic processes involving glycine, serine, and threonine. Glycine is the predominant amino acid for mammals and other animals. Glycine is synthesized through inter-organ metabolism primarily involving the liver and kidneys, using serine, threonine, choline, and hydroxyproline as precursor molecules. Glycine plays a significant role in metabolic regulation, antioxidant response, and neurological function. Thus, glycine has been utilized in various applications, including the prevention of tissue damage, enhancement of antioxidant capacity, promotion of protein synthesis and wound healing, and amelioration of metabolic disturbances in disorders such as cancer and inflammatory diseases (Wang et al., 2013a). In glycine, serine, and threonine metabolism, pyruvate serves as the end product of glycolysis. Furthermore, pyruvate acts as a pivotal intersection point for various metabolic pathways involved in ATP production and maintaining homeostasis of carbohydrates, fats, and amino acids (Jeoung et al., 2014; Olenchock & Vander Heiden, 2013). Numerous studies have demonstrated the significance of glycolytic metabolism in inflammation (Cheng et al., 2014; Cheng et al., 2016). Lactate, a byproduct of glycolysis, has been identified as a crucial mediator of inflammatory responses in macrophages (Tan et al., 2015; Wei et al., 2015; Peter et al., 2015). Classically activated macrophages rely on glycolysis and glutamine metabolism to produce substantial amounts of succinate, which in turn promotes inflammation and interleukin-1 production (Tannahill et al., 2013). Inhibition of glycolysis is characterized by a decrease in concentrations of pyruvate and lactate (Tan et al., 2020). In mammals, CBS is involved in the initiation and rate-limiting step of the transsulfuration pathway, responsible for generating endogenous H2S (hydrogen sulfide) through the enzymatic pathway. In the cardiovascular system, endogenous H2S catalyzed by CSE (cystathionine-γ-lyase) can regulate vascular tension, promote angiogenesis, and protect the heart (Li et al., 2011). In the nervous system, CBS is primarily found in astrocytes and neural stem cells, contributing to endothelial function protection through its anti-inflammatory, antioxidant, and angiogenic effects (Wang et al., 2013b). Rutin is found to negatively regulate RhoA/ROCK signaling by promoting the expression of CBS, effectively inhibiting the inflammatory progression of osteoarthritis (Sui et al., 2022). Protein kinase RNA-like ER kinase (PERK) is a key metabolic center for the immunosuppressive function of macrophages. The α-KG is an important cofactor for JMJD3 histone demethylation, and JMJD3-α-KG signaling is associated with M2 activation in macrophages (Vitale et al., 2019). Furthermore, α-KG supplementation can alleviate the osteoarthritic phenotype by modulating mitophagy and oxidative stress, suggesting its potential as a therapeutic target to improve osteoarthritis (Liu et al., 2023). The reduced immunosuppressive M2 properties resulting from PSAT1 and PERK deficiency may be due to reduced histone demethylation and limited α-KG availability. The relationship between PERK and PSAT1-mediated serine biosynthesis opens up possibilities for reprogramming or editing M2 macrophages, which may benefit the treatment of cancer or other inflammatory diseases (Raines et al., 2022).
In the pathophysiological process of osteoarthritis, there is a significant increase in pro-inflammatory and pro-catabolic factors, leading to accelerated catabolism and disruption of the dynamic balance of cell metabolism (Loeser, 2011). In this situation, cells respond by increasing anabolism through processes such as proliferation and protein synthesis to maintain the dynamic balance between anabolism and catabolism. Unlike those in a fully differentiated and quiescent state, chondrocytes in an inflammatory microenvironment undergo adaptive changes in their energy metabolism. This is characterized by a significant increase in glycolysis, while reliance on aerobic metabolism through the mitochondrial tricarboxylic acid cycle is greatly reduced (Mobasheri et al., 2017). Chondrocytes also can sense the concentration of oxygen and glucose in the ECM and respond accordingly by regulating cellular metabolism. This adaptive response allows chondrocytes to rely more on anaerobic glycolysis for energy production during periods of acute nutritional and oxygen stress (Lotz & Loeser, 2012).
In the pathogenesis of osteoarthritis, there is excessive production of nitric oxide by chondrocytes, which significantly impairs mitochondrial function and consequently reduces ATP synthesis. To meet the energy demands of chondrocytes, there is an upregulation of glycolysis to enhance ATP production (Lane et al., 2015). There is a significant increase in glycolysis levels in articular chondrocytes of patients with osteoarthritis (Maneiro et al., 2003). The altered energy metabolism in chondrocytes results in a significant reduction in the amount of pyruvate entering the tricarboxylic acid cycle. Instead, pyruvate in the cytoplasm is converted into lactate, a metabolic end product, through the action of lactate dehydrogenase. This accumulation of lactate in the cytoplasm further lowers the pH value of the already acidic microenvironment, leading to extracellular acidosis (Richardson et al., 2010). Research indicates that patients with osteoarthritis have lower pH levels and lower pH measurements are associated with more severe symptoms and impaired knee function (Lombardi et al., 2022).
Mitochondria are the power centers of cells, which provide energy in the form of ATP for cell activity, differentiation, death, signal regulation, and cell cycle control (Shutt & Shadel, 2010). Mitochondria are also molecular platforms for the integration of multiple innate immune signaling pathways (Monlun et al., 2017). Mitochondrial dysfunction and oxidative stress are important hallmarks of abnormal metabolism in osteoarthritis (Loeser et al., 2016). In the process of degenerative diseases including osteoarthritis, changes in mitochondrial structure, dynamics, and genome stability lead to a decline in mitochondrial respiratory function, excessive synthesis of reactive oxygen species (ROS), and oxidative damage. Compared with healthy individuals, the mitochondrial DNA damage of chondrocytes in osteoarthritis patients was significantly increased, while the repair ability was significantly decreased, increasing the apoptosis rate of chondrocytes (Grishko et al., 2009). The maintenance of mitochondrial membrane potential is important for promoting oxidative phosphorylation and synthesis of ATP. The analysis of mitochondrial electron transport chain activities shows that the mitochondrial membrane potential of chondrocytes as well as the content of complexes II and III in patients with osteoarthritis decreased significantly (Maneiro et al., 2003). Although the majority of ATP in chondrocytes comes from glycolysis rather than oxidative phosphorylation (Mobasheri et al., 2005), mitochondrial ROS help maintain cellular redox balance to promote glycolysis (Martin et al., 2012). The weakening of the energy storage capacity of chondrocytes and the shift of metabolic pathway to glycolysis lead to impaired cellular anabolism, decreased ECM synthesis (Johnson et al., 2000; Cillero-Pastor et al., 2013), and reduced cell viability. The massive synthesis of nitric oxide and ROS induces more mitochondrial DNA damage and inhibition of mitochondrial oxidative phosphorylation (Henrotin et al., 2003; Johnson et al., 2001; Reed et al., 2014). Active lipid peroxidation in articular chondrocytes of osteoarthritis patients leads to accelerated mitochondrial DNA damage in chondrocytes, which acts as a feed-forward loop, thereby affecting chondrocyte telomeric DNA and replicative lifespan, and destroying the integrity of cartilage proteoglycans (Martin & Buckwalter, 2002; Yudoh et al., 2005).
Conclusion
Overall, we postulate that curcumin might have therapeutic potential in the management of osteoarthritis by targeting CBS, PSAT1, MAOA, and other crucial proteins. However, further experimental verification is required to ascertain the regulatory effect of curcumin on specific targets.
Data availability
The data that support the findings of this study are available on request from the corresponding author, Qinghu He, upon reasonable request. The RNA-seq data have been deposited in GEO, under the accession number of GSE243421.
References
Abdi H, Williams LJ (2010) Principal component analysis. Wiley Interdiscip Rev: Comput Statis 2(4):433–459
Alseekh S, Aharoni A (2021) Mass spectrometry-based metabolomics: a guide for annotation, quantification and best reporting practices. Nat Methods 18(7):747–756
Atabaki M et al (2020) Significant immunomodulatory properties of curcumin in patients with osteoarthritis; a successful clinical trial in Iran. Int Immunopharmacol 85:106607
Ataei M et al (2023) Recent advances in curcumin-based nanoformulations in diabetes. J Drug Target 31(7):671–684
Bergholt MS et al (2016) Raman spectroscopy reveals new insights into the zonal organization of native and tissue-engineered articular cartilage. ACS Cent Sci 2(12):885–895
Boccard J, Rutledge DN (2013) A consensus orthogonal partial least squares discriminant analysis (OPLS-DA) strategy for multiblock Omics data fusion. Anal Chim Acta 769:30–39
Carcolé M et al (2019) Sigma-1 receptor modulates neuroinflammation associated with mechanical hypersensitivity and opioid tolerance in a mouse model of osteoarthritis pain. British J Pharm 176(20):3939–3955
Chang SH et al (2019) Excessive mechanical loading promotes osteoarthritis through the gremlin-1-NF-κB pathway. Nat Commun 10(1):1442
Cheng SC, Joosten LA, Netea MG (2014) The interplay between central metabolism and innate immune responses. Cytokine Growth Factor Rev 25(6):707–713
Cheng SC et al (2016) Broad defects in the energy metabolism of leukocytes underlie immunoparalysis in sepsis. Nat Immunol 17(4):406–413
Cillero-Pastor B et al (2013) Mitochondrial respiratory chain dysfunction modulates metalloproteases -1, -3 and -13 in human normal chondrocytes in culture. BMC Musculoskelet Disord 14:235
Doppler M et al (2016) Stable isotope-assisted evaluation of different extraction solvents for untargeted metabolomics of plants. Int J Mol Sci 17(7)
Dunn WB et al (2011) Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry. Nat Protoc 6(7):1060–1083
Frantz S et al (2018) The innate immune system in chronic cardiomyopathy: a European Society of Cardiology (ESC) scientific statement from the Working Group on Myocardial Function of the ESC. Eur J Heart Fail 20(3):445–459
Grishko VI et al (2009) Diminished mitochondrial DNA integrity and repair capacity in OA chondrocytes. Osteoarthr Cartil 17(1):107–113
Heidari-Beni M, Moravejolahkami AR (2020) Herbal formulation “turmeric extract, black pepper, and ginger” versus Naproxen for chronic knee osteoarthritis: a randomized, double-blind, controlled clinical trial. Phytother Res 34(8):2067–2073
Henrotin YE, Bruckner P, Pujol JP (2003) The role of reactive oxygen species in homeostasis and degradation of cartilage. Osteoarthr Cartil 11(10):747–755
Hootman JM, Helmick CG (2006) Projections of US prevalence of arthritis and associated activity limitations. Arthritis Rheum 54(1):226–229
Iolascon G, Giménez S, Mogyorósi D (2021) A review of aceclofenac: analgesic and anti-inflammatory effects on musculoskeletal disorders. J Pain Res 14:3651–3663
Jeon OH et al (2017) Local clearance of senescent cells attenuates the development of post-traumatic osteoarthritis and creates a pro-regenerative environment. Nat Med 23(6):775–781
Jeoung NH, Harris CR, Harris RA (2014) Regulation of pyruvate metabolism in metabolic-related diseases. Rev Endocr Metab Disord 15(1):99–110
Johnson K et al (2000) Mitochondrial oxidative phosphorylation is a downstream regulator of nitric oxide effects on chondrocyte matrix synthesis and mineralization. Arthritis Rheum 43(7):1560–1570
Johnson K et al (2001) Up-regulated expression of the phosphodiesterase nucleotide pyrophosphatase family member PC-1 is a marker and pathogenic factor for knee meniscal cartilage matrix calcification. Arthritis Rheum 44(5):1071–1081
Kang C et al (2020) Acid-activatable polymeric curcumin nanoparticles as therapeutic agents for osteoarthritis. Nanomedicine 23:102104
Koroljević ZD et al (2023) Curcuma as an anti-inflammatory component in treating osteoarthritis. Rheumatol Int 43(4):589–616
Kotha RR, Luthria DL (2019) Curcumin: biological, pharmaceutical, nutraceutical, and analytical aspects. Molecules 24(16)
Kou H et al (2023) Effect of curcumin on rheumatoid arthritis: a systematic review and meta-analysis. Front Immunol 14:1121655
Kovaka S et al (2019) Transcriptome assembly from long-read RNA-seq alignments with StringTie2. Genome Biol 20(1):278
Lam KN, Alexander M, Turnbaugh PJ (2019) Precision medicine goes microscopic: engineering the microbiome to improve drug outcomes. Cell Host Microbe 26(1):22–34
Lane RS et al (2015) Mitochondrial respiration and redox coupling in articular chondrocytes. Arthritis Res Ther 17(1):54
Li L, Rose P, Moore PK (2011) Hydrogen sulfide and cell signaling. Annu Rev Pharmacol Toxicol 51:169–187
Liu L et al (2023) The physiological metabolite α-ketoglutarate ameliorates osteoarthritis by regulating mitophagy and oxidative stress. Redox Biol 62:102663
Liu W et al (2020) INSR mediated by transcription factor KLF4 and DNA methylation ameliorates osteoarthritis progression via inactivation of JAK2/STAT3 signaling pathway. Am J Transl Res 12(12):7953–7967
Loeser RF (2011) Aging and osteoarthritis. Curr Opin Rheumatol 23(5):492–496
Loeser RF, Collins JA, Diekman BO (2016) Ageing and the pathogenesis of osteoarthritis. Nat Rev Rheumatol 12(7):412–420
Lombardi AF et al (2022) AcidoCEST-UTE MRI reveals an acidic microenvironment in knee osteoarthritis. Int J Mol Sci 23:8
Lotz M, Loeser RF (2012) Effects of aging on articular cartilage homeostasis. Bone 51(2):241–248
Luo W et al (2023) Polysaccharides-based nanocarriers enhance the anti-inflammatory effect of curcumin. Carbohydr Polym 311:120718
Maneiro E et al (2003) Mitochondrial respiratory activity is altered in osteoarthritic human articular chondrocytes. Arthritis Rheum 48(3):700–708
Martin JA, Buckwalter JA (2002) Aging, articular cartilage chondrocyte senescence and osteoarthritis. Biogerontology 3(5):257–264
Martin JA et al (2012) Mitochondrial electron transport and glycolysis are coupled in articular cartilage. Osteoarthr Cartil 20(4):323–329
Miller RJ, Malfait AM, Miller RE (2020) The innate immune response as a mediator of osteoarthritis pain. Osteoarthr Cartil 28(5):562–571
Mobasheri A et al (2005) Hypoxia inducible factor-1 and facilitative glucose transporters GLUT1 and GLUT3: putative molecular components of the oxygen and glucose sensing apparatus in articular chondrocytes. Histol Histopathol 20(4):1327–1338
Mobasheri A et al (2017) The role of metabolism in the pathogenesis of osteoarthritis. Nat Rev Rheumatol 13(5):302–311
Monlun M et al (2017) Mitochondria as molecular platforms integrating multiple innate immune signalings. J Mol Biol 429(1):1–13
Nakagawa Y et al (2020) The efficacy and safety of highly-bioavailable curcumin for treating knee osteoarthritis: a 6-month open-labeled prospective study. Clin Med Insights Arthritis Musculoskelet Disord 13:1179544120948471
Olenchock BA, Vander Heiden MG (2013) Pyruvate as a pivot point for oncogene-induced senescence. Cell 153(7):1429–1430
Pang Z et al (2021) MetaboAnalyst 5.0: narrowing the gap between raw spectra and functional insights. Nucleic Acids Res 49(W1):W388–w396
Panknin TM et al (2023) Curcumin supplementation and human disease: a scoping review of clinical trials. Int J Mol Sci 24(5)
Park S et al (2016) Curcumin and tetrahydrocurcumin both prevent osteoarthritis symptoms and decrease the expressions of pro-inflammatory cytokines in estrogen-deficient rats. Genes Nutr 11:2
Peng J et al (2015) An integrated targeted metabolomic platform for high-throughput metabolite profiling and automated data processing. Metabolomics: Official J Metabol Soc 11(6):1575–1586
Pertea M et al (2015) StringTie enables improved reconstruction of a transcriptome from RNA-seq reads. Nat Biotechnol 33(3):290–295
Pertea M et al (2016) Transcript-level expression analysis of RNA-seq experiments with HISAT. StringTie Ballgown 11(9):1650–1667
Peter K et al (2015) Lactic acid delays the inflammatory response of human monocytes. Biochem Biophys Res Commun 457(3):412–418
Raines LN et al (2022) PERK is a critical metabolic hub for immunosuppressive function in macrophages. Nat Immunol 23(3):431–445
Razali NSC et al (2022) Curcumin piperidone derivatives induce anti-proliferative and anti-migratory effects in LN-18 human glioblastoma cells. Sci Rep 12(1):13131
Reed KN et al (2014) The role of mitochondrial reactive oxygen species in cartilage matrix destruction. Mol Cell Biochem 397(1-2):195–201
Richardson SM et al (2010) Mesenchymal stem cells in regenerative medicine: opportunities and challenges for articular cartilage and intervertebral disc tissue engineering. J Cell Physiol 222(1):23–32
Robinson MD, McCarthy DJ, Smyth GK (2010) edgeR: a bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26(1):139–140
Rowland CR et al (2018) Regulation of decellularized tissue remodeling via scaffold-mediated lentiviral delivery in anatomically-shaped osteochondral constructs. Biomaterials 177:161–175
Sahraeian SME et al (2017) Gaining comprehensive biological insight into the transcriptome by performing a broad-spectrum RNA-seq analysis. Nat Commun 8(1):59
Schulze-Tanzil G (2019) Intraarticular ligament degeneration is interrelated with cartilage and bone destruction in osteoarthritis. Cells 8(9)
Shen S et al (2019) CircSERPINE2 protects against osteoarthritis by targeting miR-1271 and ETS-related gene. Ann Rheum Dis 78(6):826–836
Shutt TE, Shadel GS (2010) A compendium of human mitochondrial gene expression machinery with links to disease. Environ Mol Mutagen 51(5):360–379
Smith CA et al (2006) XCMS: processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification. Anal Chem 78(3):779–787
Srivastava S et al (2016) Curcuma longa extract reduces inflammatory and oxidative stress biomarkers in osteoarthritis of knee: a four-month, double-blind, randomized, placebo-controlled trial. Inflammopharmacology 24(6):377–388
Sui C et al (2022) Rutin inhibits the progression of osteoarthritis through CBS-mediated RhoA/ROCK Signaling. DNA Cell Biol 41(6):617–630
Tajerian M et al (2018) The hippocampal extracellular matrix regulates pain and memory after injury. Molecul Psych 23(12):2302–2313
Tan M, Mosaoa R, Graham GT (2020) Inhibition of the mitochondrial citrate carrier, Slc25a1, reverts steatosis, glucose intolerance, and inflammation in preclinical models of NAFLD/NASH. Cell Death Differ 27(7):2143–2157
Tan Z et al (2015) The monocarboxylate transporter 4 is required for glycolytic reprogramming and inflammatory response in macrophages. J Biol Chem 290(1):46–55
Tannahill GM et al (2013) Succinate is an inflammatory signal that induces IL-1β through HIF-1α. Nature 496(7444):238–242
Thomas JV et al (2021) Influence of a low-dose supplementation of curcumagalactomannoside complex (CurQfen) in knee osteoarthritis: A randomized, open-labeled, active-controlled clinical trial. Phytother Res 35(3):1443–1455
Vitale I et al (2019) Macrophages and metabolism in the tumor microenvironment. Cell Metab 30(1):36–50
Wanchoo R et al (2017) Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review. Am J Nephrol 45(2):160–169
Wang W et al (2013a) Glycine metabolism in animals and humans: implications for nutrition and health. Amino Acids 45(3):463–477
Wang Z et al (2013b) L-Cysteine promotes the proliferation and differentiation of neural stem cells via the CBS/H2S pathway. Neuroscience 237:106–117
Wang ZY, Leushkin E, Liechti A (2020) Transcriptome and translatome co-evolution in mammals. Nature 588(7839):642–647
Want EJ et al (2010) Global metabolic profiling procedures for urine using UPLC-MS. Nat Protoc 5(6):1005–1018
Wei L et al (2015) Lactate promotes PGE2 synthesis and gluconeogenesis in monocytes to benefit the growth of inflammation-associated colorectal tumor. Oncotarget 6(18):16198–16214
Yaribeygi H et al (2023) The beneficial effects of curcumin on lipids: possible effects on dyslipidemia-induced cardiovascular complications. Curr Med Chem
Yoon YS et al (2023) Antinociceptive and anti-inflammatory activity of DW-1021, the ionic complex of pelubiprofen and tramadol, in rodents. Biomed Pharmacother 163:114708
Yoshizumi T et al (2016) Timing effect of intramyocardial hydrogel injection for positively impacting left ventricular remodeling after myocardial infarction. Biomaterials 83:182–193
You R, Liu S, Tan J (2022) Screening and identification of osteoarthritis related differential genes and construction of a risk prognosis model based on bioinformatics analysis. Ann Transl Med 10(8):444
Yudoh K et al (2005) Potential involvement of oxidative stress in cartilage senescence and development of osteoarthritis: oxidative stress induces chondrocyte telomere instability and downregulation of chondrocyte function. Arthritis Res Ther 7(2):R380–R391
Zeng L et al (2022) Efficacy and safety of curcumin and curcuma longa extract in the treatment of arthritis: a systematic review and meta-analysis of randomized controlled trial. Front Immunol 13:891822
Zhang Y, Zeng Y (2019) Curcumin reduces inflammation in knee osteoarthritis rats through blocking TLR4/MyD88/NF‐κB signal pathway. Drug Dev Res 80(3):353–359
Zhang Z et al (2016) Curcumin slows osteoarthritis progression and relieves osteoarthritis-associated pain symptoms in a post-traumatic osteoarthritis mouse model. Arthritis Res Ther 18(1):128
Zhang ZJ et al (2023) A pH-responsive metal-organic framework for the co-delivery of HIF-2α siRNA and curcumin for enhanced therapy of osteoarthritis. J Nanobiotechnol 21(1):18
Funding
This study was supported by Research Project of Hunan Medical College (Grant No. HYH-2021Y-KJ-6-33), Hunan University of Traditional Chinese Medicine (Grant No. 2022MKZJ06), Hunan Natural Science Foundation Youth Fund Project (Grant No. 2022JJ40299), Hunan Provincial Department of Education Science Research Project (Grant No. 21C0223), Project of Hunan Provincial Health Commission (Grant No. D202302086054), National Natural Science Project (Grant No. 81973863), and Special Project of Traditional Chinese Medicine Science and Technology Research of Guangdong Provincial Hospital of Traditional Chinese Medicine (Grant No. YN2019ML15),Science and Technology Bureau of Zhuhai City (Grant No. ZH2202200018HJL),Guangdong Provincial Hospital of Traditional Chinese Medicine (Grant No. DF02201).
Author information
Authors and Affiliations
Contributions
Qinghu He designed the study, supervised the data collection; Wenan Zhang analyzed the data, interpreted the data; Wenxiang Deng prepares the manuscript for publication and reviewed the draft of the manuscript. All authors have read and approved the manuscript. The authors declare that all data were generated in-house and that no paper mill was used.
Corresponding author
Ethics declarations
Ethical approval
Not applicable.
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Deng, W., He, Q. & Zhang, W. Analysis of the mechanism of curcumin against osteoarthritis using metabolomics and transcriptomics. Naunyn-Schmiedeberg's Arch Pharmacol 397, 3313–3329 (2024). https://doi.org/10.1007/s00210-023-02785-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00210-023-02785-y